Registered entities
Halozyme, Inc.
Reg. No. 330802801United States
HALOZYME THERAPEUTICS, INC
Reg. No. 88-0488686United States
HALOZYME THERAPEUTICS INC
Reg. No. 1159036United States
Innovation
77 patent families (41 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing, Emerging technologies; filing pace accelerating. Cited 52,906 times.
| Year | Filings |
|---|---|
| 2015 | 21 |
| 2016 | 23 |
| 2017 | 20 |
| 2018 | 16 |
| 2019 | 13 |
| 2020 | 9 |
| 2021 | 5 |
| 2022 | 9 |
| 2023 | 12 |
| 2024 | 10 |
| 2025 | 24 |
| 2026 | 13 |
Social engagement
Social engagement: 24.4K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
10 investors on record; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 30% |
| Private equity | 4 | 40% |
| Bank & private debt | 1 | 10% |
| Other / undisclosed | 2 | 20% |
Hiring activity
Hires periodically
9 roles tracked across 4 of the last 12 months
4 Mar 2026 · Associate Director, Project Management · San Diego
2 Feb 2026 · Manager, Contracts · San Diego
9 Jan 2026 · Vice President, Corporate Development · San Diego
9 Jan 2026 · Specialty Account Manager - Thousand Oaks, CA · Murrieta
16 Nov 2025 · Patent AgentAttorney · San Diego
Based on job postings tracked across public sources.
Recent activity
18 Jun 2026
Event
Controlled Release Society (CRS) 2026 Annual Meeting
7 May 2026
Partnership
Oruka Therapeutics
8 Apr 2026
Partnership
Vertex Pharmaceuticals